Ecolab's (ECL) deal to sell its global surgical solutions business to Medline enables it to focus on infection prevention and instrument reprocessing while enhancing shareholders' returns.

ST. PAUL, Minn.--(BUSINESS WIRE)--The board of directors of Ecolab Inc. today declared a regular quarterly cash dividend of $0.57 per common share, to be paid October 15, 2024, to shareholders of record at the close of business on September 17, 2024. Ecolab has paid cash dividends on its common stock for 87 consecutive years. About Ecolab A trusted partner for millions of customers, Ecolab (NYSE:ECL) is a global sustainability leader offering water, hygiene and infection prevention solutions an.

Ecolab Inc. (NYSE:ECL ) Q2 2024 Earnings Conference Call July 30, 2024 1:00 PM ET Company Participants Andy Hedberg - Vice President, Investor Relations Christophe Beck - Chairman & Chief Executive Officer Scott Kirkland - Chief Financial Officer Conference Call Participants Tim Mulrooney - William Blair Ashish Sabadra - RBC Capital Markets Ronan Kennedy - Barclays John Roberts - Mizuho Securities Lucas Beaumont - UBS Chris Parkinson - Wolfe Research John McNulty - BMO Capital Markets Jeff Zekauskas - JPMorgan David Begleiter - Deutsche Bank Pavel Molchanov - Raymond James Shlomo Rosenbaum - Stifel Steve Byrne - Bank of America Kevin McCarthy - Vertical Research Patrick Cunningham - Citi Andy Wittmann - Robert W. Baird Mike Harrison - Seaport Research Vincent Andrews - Morgan Stanley Operator Greetings.

Ecolab's (ECL) robust performance across the majority of its segments drives its second-quarter sales amid business challenges.

While the top- and bottom-line numbers for Ecolab (ECL) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Ecolab (ECL) came out with quarterly earnings of $1.68 per share, beating the Zacks Consensus Estimate of $1.66 per share. This compares to earnings of $1.24 per share a year ago.

ST. PAUL, Minn.--(BUSINESS WIRE)--Ecolab Inc. (NYSE: ECL): SECOND QUARTER HIGHLIGHTS Reported sales $4.0 billion, +3% versus last year, including a 1% headwind from unfavorable foreign currency exchange. Organic sales +4% as Institutional & Specialty segment sales growth normalized to a strong +7% as expected. The segment lapped last year's very strong pricing delivery. Performance across the Pest Elimination, Industrial and Healthcare & Life Sciences segments all improved. Reported ope.

Get a deeper insight into the potential performance of Ecolab (ECL) for the quarter ended June 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.

Ecolab's (ECL) second-quarter results are likely to reflect continued segmental strength.

Dividend aristocrats are stocks with at least 25 years of consecutive annual dividend growth. These “regal” dividend stocks are often considered some of the highest-quality long-term stocks to buy and hold.

Going into the Q2 earnings season, earnings releases from the sector giants will determine the movement of these funds.

In many parts of the world, it's either difficult for consumers and farmers to access enough fresh clean water, or it's getting significantly harder to do so. According to Fidelity, roughly 2 billion individuals worldwide are unable to obtain fresh drinking water.